In lung cancer, cancer cells can secrete TGF‐β and IL‐10 to induce naïve T cells to differentiate into Tregs, and tumour antigens presented by APCs further enhance Treg activation and accumulation in the tumour microenvironment, where Tregs inhibit NK cell‐mediated cytotoxicity [45]. This evidence concerns the gene IL10 and neoplasm.